Page results
-
At your first visit to UCLH your midwife will discuss birth place options with you and recommend a place of birth.
-
Postnatal care should be a continuation of the care the woman has received through her pregnancy, labour and birth and take into account the woman’s individual needs and preferences.
-
Omnipod 5 users will get a notification on their Omnipod 5 Controller to install a software update (version 2.0).
-
This series of wellbeing videos have been designed to help people manage the side effects of cancer treatment.
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
Martha’s Rule is a national patient safety initiative, which gives patients and families access to an urgent review from our Critical Care Outreach Team if they are worried that the inpatient’s condition is getting worse.
-
We welcome your feedback about your experience of NHNN and NCC. Your comments will be used to monitor and improve the service we provide.
-
This information has been written by Psychological Therapy Services Team at the Royal London Hospital for Integrated Medicine. It is intended for clients or their family or carers who may be referred to this clinic.
-
I would like to make a payment to UCLH, I have a query about reclaiming expenses for treatment or transport at University College Hospital or I have a query about expenses for treatment or transport at Queen Square (NHNN/RLHIM)
-
Dr Maria Michelagnoli is a paediatric oncologist with a special interest in bone tumours, rhabdomyosarcoma, fibromatosis and bone presentations of LCH
File results
-
FOI/2023/0299 - Trust Medical Examiner contact details
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022
-
FOI/2023/0340 - NHS charging of overseas visitors
-
FOI/2023/0341 - Senior staff contact details
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care